BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1405317)

  • 1. Extrarenal cytokines modulate the glomerular response to IgA immune complexes.
    Montinaro V; Hevey K; Aventaggiato L; Fadden K; Esparza A; Chen A; Finbloom DS; Rifai A
    Kidney Int; 1992 Aug; 42(2):341-53. PubMed ID: 1405317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy.
    Chao TK; Rifai A; Ka SM; Yang SM; Shui HA; Lin YF; Sytwu HK; Lee WH; Kung JT; Chen A
    Kidney Int; 2006 Jul; 70(2):283-97. PubMed ID: 16738538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
    Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
    J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotype antibody directly interferes with glomerular IgA immune complex deposition.
    Chen A; Sheu LF; Shaio MF; Huang TH; Ding SL; Lee WH
    Nephron; 1998; 78(4):464-73. PubMed ID: 9578073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
    Rifai A; Chen A; Imai H
    Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular electron-dense deposits in childhood IgA nephropathy.
    Yoshikawa N; Ito H; Nakahara C; Yoshiara S; Yoshiya K; Matsuo T; Hasegawa O; Hazikano H; Okada S
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):33-43. PubMed ID: 3158115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy: immune mechanisms beyond IgA mesangial deposition.
    Rifai A
    Kidney Int; 2007 Aug; 72(3):239-41. PubMed ID: 17653232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy.
    Montinaro V; Aventaggiato L; Cavallo T; Rifai A
    Nephrol Dial Transplant; 1995 Nov; 10(11):2035-42. PubMed ID: 8643164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS
    J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IgA nephropathy].
    Basta-Jovanović G
    Srp Arh Celok Lek; 2004; 132(1-2):41-3. PubMed ID: 15227965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of cytokine expression in patients with IgA nephropathy.
    Yano N; Endoh M; Nomoto Y; Sakai H; Fadden K; Rifai A
    J Clin Immunol; 1997 Sep; 17(5):396-403. PubMed ID: 9327339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental IgA nephropathy.
    Rifai A; Small PA; Teague PO; Ayoub EM
    J Exp Med; 1979 Nov; 150(5):1161-73. PubMed ID: 159331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy.
    Tsushima Y; Tomino Y; Shimizu M; Ohmuro H; Takeuchi K; Kuramoto T; Shirato I; Koide H
    Nephron; 1994; 66(1):81-6. PubMed ID: 7906404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.
    Chen A; Wong SS; Rifai A
    Am J Pathol; 1988 Jan; 130(1):216-22. PubMed ID: 3276211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.
    Lamm ME; Emancipator SN; Robinson JK; Yamashita M; Fujioka H; Qiu J; Plaut AG
    Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.